Intranasal Drug and Vaccine Delivery - Global Market Outlook (2019 -2027)
According to Stratistics MRC, the Global Intranasal Drug and Vaccine Delivery Market is accounted for $46.20 billion in 2019 and is expected to reach $88.75 billion by 2027 growing at a CAGR of 8.5% during the forecast period. Growing preference for nasal products, increasing prevalence of respiratory and neurological diseases, and surge in intranasal product launches are the major factors propelling the market growth. However, moderate complications and side effects associated with the use of nasal products are hampering the market growth.
Drug delivery refers to a process of delivering a drug into the patient’s body to have an effective therapeutic effect. Different modes are used for the delivery of drug. Nasal and pulmonary routes are most popular modes for delivering drug. The global drug delivery market is growing at a significant rate due to growing awareness in the field and technical innovations in the field. Intranasal drug delivery refers to a process of delivering the administered drug through nasal route. Drugs that are delivering through nasal means may be prescribed for acute or chronic treatments. Various types of drugs that are delivered through nasal cavity are local anaesthetics, antibiotics, pain relief drugs, calcium supplements, vasoconstrictors, snuffs, antihistamines and others.
Based on the distribution channel, the online pharmacies segment is going to have a lucrative growth during the forecast period due to the discounts offered, as well as cost-effectiveness to patients and payers in the long run. Moreover, increasing inclination towards online purchases has brought advantages to the online pharmacies segment.
By geography, Asia Pacific is going to have a lucrative growth during the forecast period due to the increasing product development protocols, economic growth, and increase in the number of local market players involved in the development of novel drug delivery systems. China and India are expected to be the fastest growing intranasal drug delivery markets in Asian region. This is due to large investment by various major companies in these countries. Some of the key driving forces for intranasal drug delivery market in emerging countries are large pool of patients, rising government funding and improvement in the healthcare facilities.
Some of the key players profiled in the Intranasal Drug and Vaccine Delivery Market include 3M, Aptar Pharma, Bespak, GlaxoSmithKline Plc, Intersect ENT, OptiNose, Inc., Teleflex Corporation, Teva Pharmaceuticals, and UCB, Inc.
• Liquid Delivery Device
• Powder Delivery Device
• Pressurized Metered Dose Inhaler
• Neurological Disorder
• Pain Management
• Respiratory Disorders
Distribution Channels Covered:
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019 2020, 2024, and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.